TISSIUM selected for the French Tech 120 Program
Paris, France, June 5, 2025 -- TISSIUM, a medtech company developing biomorphic programmable polymers for tissue reconstruction, confirms its selection for the sixth year in a row in the French Tech 120 Program by joining the 2025 class.
Launched in 2019 by the Mission French Tech, the French Tech 120 is a program from the Government to support the 120 most promising French start-ups, who have the potential to become world-class technology leaders.
TISSIUM will benefit from daily, personalized support throughout the 2025 class. The aim of the program is to provide individual and collective support on strategic issues such as international development, financing, recruitment, industrial implantation, intellectual property, and regulatory issues. Start-ups will thus be able to rely on a dedicated start-up manager within the Mission French Tech, enhanced visibility, specific support on regulatory issues, and collective support in the form of experience-sharing events and expertise contributions.
'We are delighted to once again be part of the French Tech 120 program, particularly in 2025 where we continue the expansion of our activities in each of our therapeutic indications and the achievement of important clinical and regulatory milestones in preparation for the upcoming commercialization of our first products. For the sixth consecutive year, this recognition is a validation of our ongoing commitment to innovate and grow in order to transform the field of tissue reconstruction.' said Christophe Bancel, CEO of TISSIUM.
About Mission French Tech
Mission French Tech is the government mission tasked, since 2013, with supporting the structuring and growth of the French start-up ecosystem, in France and internationally. Attached to the Direction Générale des Entreprises, within the Ministère de l'Économie, des Finances et de la Souveraineté Industrielle et Numérique, it federates and animates the French Tech ecosystem with a network of 17 Capitales and nearly a hundred labeled French Tech Communities, in France and in 52 countries around the world.
It also supports start-ups by facilitating their interactions with the administration via a network of over 60 French Tech correspondents. Mission French Tech supports the most mature start-ups through the French Tech Next40/120 program and start-ups positioned in sectors identified as strategic within the framework of France 2030 with the French Tech 2030 program.
Find all the information on the French Tech Next40/120 on the Mission French Tech website: www.lafrenchtech.com/en
Mission French Tech press contact: ft.presse@finances.gouv.fr
About TISSIUM
TISSIUM is a MedTech company headquartered in Paris, France, with operations in Cambridge, USA, and a manufacturing site in the North of France (Ronq). The company is pioneering a proprietary platform of fully biosynthetic, biomorphic, and programmable polymers designed to address critical unmet needs in atraumatic tissue repair and tissue reconstruction.
TISSIUM's diversified pipeline includes seven products across three core verticals: sutureless nerve repair, atraumatic hernia repair, and cardiovascular sealants. Each solution is engineered to optimize tissue reconstruction through controlled and consistent application with specialized delivery and activation devices to maximize the performance and usability of its products.
Founded in 2013, TISSIUM is built on breakthrough research and intellectual property originating from the laboratories of Professor Robert Langer (MIT) and Professor Jeffrey M. Karp (Brigham and Women's Hospital).
For more information, please visit www.TISSIUM.com and follow us on LinkedIn: TISSIUM.
***
Contact
Romain Attard – Chief Financial Officer rattard@tissium.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
E&E News
32 minutes ago
- E&E News
EPA employees stream for the exit
More than 1,300 EPA employees are poised to leave the agency in what may be the single largest exodus in its history. As of Friday morning, 1,334 staffers had followed through on 'early out' offers that require them to start paid administrative leave Monday, according to figures provided by the agency. That number is about half of those who initially applied in April for early retirement as well as a second deferred resignation offer. Employees older than 40 have more time to mull their options. Those leaving make up more than 8 percent of EPA's current workforce of almost 15,700 employees, which includes about 550 who are already on leave following an earlier deferred resignation offer. The latest wave reportedly includes numerous mid-level and senior managers who will take decades of experience with them as they go out the door. Advertisement 'It's a tremendous loss for the agency and for ORD,' said Chris Frey, who served as assistant administrator of the Office of Research and Development during President Joe Biden's administration, adding that he's been 'gobsmacked' at the names of some of those who are exiting.
Washington Post
an hour ago
- Washington Post
Trump clears path for Nippon Steel investment in US Steel, so long as it fits the government's terms
WASHINGTON — President Donald Trump on Friday signed an executive order paving the way for a Nippon Steel investment in U.S. Steel , so long as the Japanese company complies with a 'national security agreement' submitted by the federal government. Trump's order didn't detail the terms of the national security agreement. But U.S. Steel and Nippon Steel said in a joint statement that the agreement stipulates that approximately $11 billion in new investments will be made by 2028 and includes giving the U.S. government a 'golden share' — essentially veto power to ensure the country's national security interests are protected.
San Francisco Chronicle
2 hours ago
- San Francisco Chronicle
Photos: Bing Crosby's historic California estate sells for $25 million
A historic Hillsborough estate once owned by Bing Crosby has sold for $25 million, more than a third below its original asking price but still one of the most expensive residential sales in the town's history. The property at 1200 Jackling Drive, a 14,000-square-foot French chateau-style mansion on 5 acres, was listed in January for $40 million following the death of Crosby's widow, Kathryn Grant, in 2024. The deal closed Thursday, June 12, according to Compass agents Alex and Pierre Buljan, who represented the buyer. 'This property is one of Hillsborough's legacy estates with an extremely storied background and impeccable vintage craftsmanship,' Alex Buljan said in a statement. 'The buyer is a Hillsborough local with an appreciation for classic properties, adamant about maintaining the character and history into the next generation.' Originally built in 1929 for the Howard family, owners of the racehorse Seabiscuit, the home was purchased by Crosby in the 1960s as a retreat from Hollywood. The singer lived there until he died in 1977, and the estate remained in the family until this year. The mansion includes 11 bedrooms, a library, a smoking room and a staff wing. Architectural features include antique paneling and a 17th century staircase acquired by the Howards from William Randolph Hearst's collection. 'If the product that a buyer is looking for is there, it is going fast,' she said. The sale is Hillsborough's highest-priced residential deal since the Western White House sold for $23 million last year, and ranks among the top five in the town's history.
